Atlas Trials

Immunotherapy Combined With Chemoradiotherapy for First-line Treatment of Esophageal Squamous Cell Carcinoma(ChinECR)

Clinical trial NCT06478355 · UNKNOWN

Trial details

NCT number
NCT06478355
Sponsor
Hebei Medical University Fourth Hospital
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
ESCC
Start date
2018-01-01
Primary completion
2025-07-01
Enrollment
800

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.